BIOPLUS LIFE CORP Proceeds from Common Stock Issued
BIOPLUS LIFE CORP reported Proceeds from Common Stock Issued of $360 for the 12-month period ending 2020-12-31, per its 10-K filed 2022-11-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2022-11-28
- BIOPLUS LIFE CORP proceeds from issuance of common stock for the quarter ending 2020-12-31 was $0.00.
- BIOPLUS LIFE CORP proceeds from issuance of common stock for the quarter ending 2020-09-30 was $0.00.
- BIOPLUS LIFE CORP proceeds from issuance of common stock for the quarter ending 2020-06-30 was $0.00.
- BIOPLUS LIFE CORP proceeds from issuance of common stock for the quarter ending 2020-03-31 was $360.00.
- BIOPLUS LIFE CORP proceeds from issuance of common stock for fiscal 2020 was $360.00.
- BIOPLUS LIFE CORP proceeds from issuance of common stock for fiscal 2018 was $585.00K.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | $0.00 derived: sum of 2 quarters · filed 2022-11-28 | $0.00 derived: sum of 3 quarters · filed 2022-11-28 | $360.00 10-K · filed 2022-11-28 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-25 | $0.00 derived: sum of 2 quarters · filed 2022-11-25 | $360.00 10-Q · filed 2022-11-25 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-25 | $360.00 10-Q · filed 2022-11-25 | ||
| 2020-03-31 | $360.00 10-Q · filed 2022-11-25 | |||
| 2018-12-31 | $396.71K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-26 | $584.80K derived: sum of 2 quarters · filed 2020-05-26 | $585.00K 10-K · filed 2020-05-26 | |
| 2018-09-30 | $188.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $188.29K 10-Q · filed 2019-11-14 | ||
| 2018-06-30 | $195.00 10-Q · filed 2019-08-14 |